269 related articles for article (PubMed ID: 8137730)
1. Is the renal type III corticosteroid-binding site the collecting duct-specific isoform of 11 beta-hydroxysteroid dehydrogenase?
Náray-Fejes-Tóth A; Rusvai E; Fejes-Tóth G
Endocrinology; 1994 Apr; 134(4):1671-5. PubMed ID: 8137730
[TBL] [Abstract][Full Text] [Related]
2. 11 beta-Hydroxysteroid dehydrogenase activity in the renal target cells of aldosterone.
Náray-Fejes-Tóth A; Watlington CO; Fejes-Tóth G
Endocrinology; 1991 Jul; 129(1):17-21. PubMed ID: 2055180
[TBL] [Abstract][Full Text] [Related]
3. Expression cloning of the aldosterone target cell-specific 11 beta-hydroxysteroid dehydrogenase from rabbit collecting duct cells.
Náray-Fejes-Tóth A; Fejes-Tóth G
Endocrinology; 1995 Jun; 136(6):2579-86. PubMed ID: 7750480
[TBL] [Abstract][Full Text] [Related]
4. Expression and characterization of a new species of 11 beta-hydroxysteroid dehydrogenase in Xenopus oocytes.
Náray-Fejes-Tóth A; Rusvai E; Denault DL; St Germain DL; Fejes-Tóth G
Am J Physiol; 1993 Dec; 265(6 Pt 2):F896-900. PubMed ID: 8285221
[TBL] [Abstract][Full Text] [Related]
5. Distribution of 11 beta-hydroxysteroid dehydrogenase along the rabbit nephron.
Bonvalet JP; Doignon I; Blot-Chabaud M; Pradelles P; Farman N
J Clin Invest; 1990 Sep; 86(3):832-7. PubMed ID: 2394832
[TBL] [Abstract][Full Text] [Related]
6. 11 beta-Hydroxysteroid dehydrogenase in renal collecting duct cells.
Náray-Fejes-Tóth A; Fejes-Tóth G
Steroids; 1994 Feb; 59(2):105-10. PubMed ID: 8191537
[TBL] [Abstract][Full Text] [Related]
7. 11 beta-hydroxysteroid dehydrogenase-2 is a high affinity corticosterone-binding protein.
Náray-Fejes-Tóth A; Fejes-Tóth G
Mol Cell Endocrinol; 1997 Nov; 134(2):157-61. PubMed ID: 9426159
[TBL] [Abstract][Full Text] [Related]
8. Minealocorticoid receptors and 11 beta-steroid dehydrogenase activity in renal principal and intercalated cells.
Náray-Fejes-Tóth A; Rusvai E; Fejes-Tóth G
Am J Physiol; 1994 Jan; 266(1 Pt 2):F76-80. PubMed ID: 8304486
[TBL] [Abstract][Full Text] [Related]
9. LLC-PK1 cells model 11 beta-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors.
Leckie C; Chapman KE; Edwards CR; Seckl JR
Endocrinology; 1995 Dec; 136(12):5561-9. PubMed ID: 7588309
[TBL] [Abstract][Full Text] [Related]
10. A new isoform of 11 beta-hydroxysteroid dehydrogenase in aldosterone target cells.
Rusvai E; Náray-Fejes-Tóth A
J Biol Chem; 1993 May; 268(15):10717-20. PubMed ID: 8496139
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and regulation of 11 beta-hydroxysteroid dehydrogenase of proximal and distal nephron.
Alfaidy N; Blot-Chabaud M; Robic D; Kenouch S; Bourbouze R; Bonvalet JP; Farman N
Biochim Biophys Acta; 1995 Apr; 1243(3):461-8. PubMed ID: 7727521
[TBL] [Abstract][Full Text] [Related]
12. 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids.
Walker BR; Yau JL; Brett LP; Seckl JR; Monder C; Williams BC; Edwards CR
Endocrinology; 1991 Dec; 129(6):3305-12. PubMed ID: 1954906
[TBL] [Abstract][Full Text] [Related]
13. Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform.
Stewart PM; Murry BA; Mason JI
J Clin Endocrinol Metab; 1994 Aug; 79(2):480-4. PubMed ID: 8045966
[TBL] [Abstract][Full Text] [Related]
14. Vasopressin potentiates mineralocorticoid selectivity by stimulating 11 beta hydroxysteroid deshydrogenase in rat collecting duct.
Alfaidy N; Blot-Chabaud M; Bonvalet JP; Farman N
J Clin Invest; 1997 Nov; 100(10):2437-42. PubMed ID: 9366557
[TBL] [Abstract][Full Text] [Related]
15. [A new regulatory mechanism of the action of corticosteroid hormones: cellular 11beta-hydroxycorticosteroid dehydrogenase].
Bonvalet JP; Kenouch S; Farman N
Bull Acad Natl Med; 1992 Apr; 176(4):569-78; discussion 579. PubMed ID: 1504875
[TBL] [Abstract][Full Text] [Related]
16. 11 beta-hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex.
Moisan MP; Seckl JR; Edwards CR
Endocrinology; 1990 Sep; 127(3):1450-5. PubMed ID: 2387261
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific distribution of the NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase.
Walker BR; Campbell JC; Williams BC; Edwards CR
Endocrinology; 1992 Aug; 131(2):970-2. PubMed ID: 1639034
[TBL] [Abstract][Full Text] [Related]
18. Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosterone-stimulated sodium transport in a novel renal cell line.
Gaeggeler HP; Gonzalez-Rodriguez E; Jaeger NF; Loffing-Cueni D; Norregaard R; Loffing J; Horisberger JD; Rossier BC
J Am Soc Nephrol; 2005 Apr; 16(4):878-91. PubMed ID: 15743993
[TBL] [Abstract][Full Text] [Related]
19. Immunodetection of 11 beta-hydroxysteroid dehydrogenase type 2 in human mineralocorticoid target tissues: evidence for nuclear localization.
Shimojo M; Ricketts ML; Petrelli MD; Moradi P; Johnson GD; Bradwell AR; Hewison M; Howie AJ; Stewart PM
Endocrinology; 1997 Mar; 138(3):1305-11. PubMed ID: 9048640
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of IMCD 11 beta-hydroxysteroid dehydrogenase type 2 by low pH and acute acid loading.
Nolan PJ; Knepper MA; Packer RK
J Am Soc Nephrol; 1997 Apr; 8(4):530-4. PubMed ID: 10495781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
